| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 217,800 | 217,227 | 204,192 | 229,398 | | Cost of Revenue | 161,781 | 165,549 | 159,904 | 176,016 | | | Gross Profit | 56,019 | 51,678 | 44,288 | 53,382 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,207 | 30,601 | 31,700 | 31,430 | | Non Recurring | 3,168 | 21,635 | (3,161) | 28,704 | | Others | 14,233 | 14,278 | 14,333 | 13,871 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,411 | (14,836) | 1,416 | (20,623) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,495 | 277 | (625) | (9,012) | | Earnings Before Interest And Taxes | 12,145 | (12,208) | 2,726 | (15,546) | | Interest Expense | 584 | 812 | 810 | 816 | | Income Before Tax | 11,561 | (13,020) | 1,916 | (16,362) | | Income Tax Expense | 4,940 | (4,380) | 920 | (5,011) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,146 | (8,640) | 996 | (11,351) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,621 | (8,640) | 996 | (11,351) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,621 | ($8,640) | $996 | ($11,351) |
|
0.51% Nasdaq 
Income Statement
